User profiles for Stephen N. Floor

Stephen N. Floor

Developing RNA Technologies @ Inceptive
Verified email at inceptive.team
Cited by 6779

[HTML][HTML] A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

…, HS Malik, DG Fujimori, T Ideker, CS Craik, SN Floor… - Nature, 2020 - nature.com
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of coronavirus disease 2019 (COVID-19), has …

Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes

…, C Coulon-Bainier, AA Banfal, SN Floor… - Nature …, 2017 - nature.com
We demonstrate editing of post-mitotic neurons in the adult mouse brain following injection
of Cas9 ribonucleoprotein (RNP) complexes in the hippocampus, striatum and cortex. …

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor

S Iwasaki, SN Floor, NT Ingolia - Nature, 2016 - nature.com
Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill
aneuploid tumour cells and repress translation of specific messenger RNAs 1 , 2 , 3 , 4 . RocA …

Tunable protein synthesis by transcript isoforms in human cells

SN Floor, JA Doudna - Elife, 2016 - elifesciences.org
10.7554/eLife.10921.001 Eukaryotic genes generate multiple RNA transcript isoforms though
alternative transcription, splicing, and polyadenylation. However, the relationship between …

CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway

…, SJ Feng, E Zelin, NL Bray, AJ Schäfer, SN Floor… - Nature …, 2018 - nature.com
CRISPR–Cas genome editing creates targeted DNA double-strand breaks (DSBs) that are
processed by cellular repair pathways, including the incorporation of exogenous DNA via …

[PDF][PDF] The translation inhibitor rocaglamide targets a bimolecular cavity between eIF4A and polypurine RNA

…, A Sakamoto, C Watanabe, Y Shichino, SN Floor… - Molecular cell, 2019 - cell.com
A class of translation inhibitors, exemplified by the natural product rocaglamide A (RocA),
isolated from Aglaia genus plants, exhibits antitumor activity by clamping eukaryotic translation …

[PDF][PDF] Pathogenic DDX3X mutations impair RNA metabolism and neurogenesis during fetal cortical development

…, G Mirzaa, C Mignot, N Miyake, N Matsumoto… - Neuron, 2020 - cell.com
De novo germline mutations in the RNA helicase DDX3X account for 1%–3% of unexplained
intellectual disability (ID) cases in females and are associated with autism, brain …

[PDF][PDF] Widespread translational remodeling during human neuronal differentiation

…, D Hockemeyer, JA Doudna, HS Bateup, SN Floor - Cell reports, 2017 - cell.com
Faithful cellular differentiation requires temporally precise activation of gene expression
programs, which are coordinated at the transcriptional and translational levels. Neurons express …

[PDF][PDF] mRNA decapping is promoted by an RNA-binding channel in Dcp2

…, BN Jones, DU Quang-Dang, J Flinders, SN Floor… - Molecular cell, 2008 - cell.com
Cap hydrolysis by Dcp2 is a critical step in several eukaryotic mRNA decay pathways.
Processing requires access to cap-proximal nucleotides and the coordinated assembly of a …

Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model

…, CR Newman, MD Montgomery, J Ou, SN Floor… - Elife, 2022 - elifesciences.org
Mutations in the RNA helicase, DDX3X, are a leading cause of Intellectual Disability and
present as DDX3X syndrome, a neurodevelopmental disorder associated with cortical …